CA2529516C - Procede et appareil permettant de fournir un gaz a une zone - Google Patents

Procede et appareil permettant de fournir un gaz a une zone Download PDF

Info

Publication number: CA2529516C
Authority: CA; Canada
Prior art keywords: gases; gas; reservoir; layer; oxygen
Prior art date: 2003-06-18
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

CA2529516A

Other languages

English (en)

Other versions

CA2529516A1 (fr

Inventor

Coni Rosati

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Oxyband Technologies Inc

Original Assignee

Oxyband Technologies Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-06-18

Filing date

2004-06-18

Publication date

2012-06-12

2004-02-18 Priority claimed from US10/781,965 external-priority patent/US7014630B2/en

2004-06-18 Application filed by Oxyband Technologies Inc filed Critical Oxyband Technologies Inc

2004-12-29 Publication of CA2529516A1 publication Critical patent/CA2529516A1/fr

2012-06-12 Application granted granted Critical

2012-06-12 Publication of CA2529516C publication Critical patent/CA2529516C/fr

2024-06-18 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

238000000034 method Methods 0.000 title claims abstract description 17
239000007789 gas Substances 0.000 claims abstract description 202
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 123
239000001301 oxygen Substances 0.000 claims abstract description 123
229910052760 oxygen Inorganic materials 0.000 claims abstract description 123
239000010410 layer Substances 0.000 claims description 102
238000004806 packaging method and process Methods 0.000 claims description 40
239000000853 adhesive Substances 0.000 claims description 23
230000004888 barrier function Effects 0.000 claims description 23
230000001070 adhesive effect Effects 0.000 claims description 22
230000002745 absorbent Effects 0.000 claims description 14
239000002250 absorbent Substances 0.000 claims description 14
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 12
239000003795 chemical substances by application Substances 0.000 claims description 12
239000000463 material Substances 0.000 claims description 11
238000012546 transfer Methods 0.000 claims description 11
230000009286 beneficial effect Effects 0.000 claims description 8
238000007789 sealing Methods 0.000 claims description 8
MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 6
229920000219 Ethylene vinyl alcohol Polymers 0.000 claims description 6
239000004715 ethylene vinyl alcohol Substances 0.000 claims description 6
238000011010 flushing procedure Methods 0.000 claims description 6
229910052757 nitrogen Inorganic materials 0.000 claims description 6
239000004698 Polyethylene Substances 0.000 claims description 5
-1 polyethylene Polymers 0.000 claims description 5
229920000573 polyethylene Polymers 0.000 claims description 5
239000003814 drug Substances 0.000 claims description 4
239000003102 growth factor Substances 0.000 claims description 4
RZXDTJIXPSCHCI-UHFFFAOYSA-N hexa-1,5-diene-2,5-diol Chemical compound OC(=C)CCC(O)=C RZXDTJIXPSCHCI-UHFFFAOYSA-N 0.000 claims description 4
229920002635 polyurethane Polymers 0.000 claims description 4
239000004814 polyurethane Substances 0.000 claims description 4
102000004190 Enzymes Human genes 0.000 claims description 3
108090000790 Enzymes Proteins 0.000 claims description 3
229940079593 drug Drugs 0.000 claims description 3
229920000915 polyvinyl chloride Polymers 0.000 claims description 3
239000004800 polyvinyl chloride Substances 0.000 claims description 3
239000004952 Polyamide Substances 0.000 claims description 2
239000012790 adhesive layer Substances 0.000 claims description 2
150000001413 amino acids Chemical class 0.000 claims description 2
230000000845 anti-microbial effect Effects 0.000 claims description 2
239000004599 antimicrobial Substances 0.000 claims description 2
239000000919 ceramic Substances 0.000 claims description 2
UFRKOOWSQGXVKV-UHFFFAOYSA-N ethene;ethenol Chemical compound C=C.OC=C UFRKOOWSQGXVKV-UHFFFAOYSA-N 0.000 claims description 2
229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
239000011159 matrix material Substances 0.000 claims description 2
239000011140 metalized polyester Substances 0.000 claims description 2
239000011707 mineral Substances 0.000 claims description 2
235000016709 nutrition Nutrition 0.000 claims description 2
239000003002 pH adjusting agent Substances 0.000 claims description 2
229920002647 polyamide Polymers 0.000 claims description 2
229920000728 polyester Polymers 0.000 claims description 2
229920000098 polyolefin Polymers 0.000 claims description 2
229920001296 polysiloxane Polymers 0.000 claims description 2
238000003825 pressing Methods 0.000 claims description 2
230000000638 stimulation Effects 0.000 claims description 2
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims 4
239000012466 permeate Substances 0.000 claims 3
MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims 2
229910002092 carbon dioxide Inorganic materials 0.000 claims 2
239000001569 carbon dioxide Substances 0.000 claims 2
229910001882 dioxygen Inorganic materials 0.000 claims 1
239000003094 microcapsule Substances 0.000 claims 1
235000015097 nutrients Nutrition 0.000 claims 1
229920000131 polyvinylidene Polymers 0.000 claims 1
229940124597 therapeutic agent Drugs 0.000 claims 1
206010052428 Wound Diseases 0.000 abstract description 66
208000027418 Wounds and injury Diseases 0.000 abstract description 66
230000029663 wound healing Effects 0.000 abstract description 10
239000010408 film Substances 0.000 description 41
230000035876 healing Effects 0.000 description 20
238000011282 treatment Methods 0.000 description 18
210000003491 skin Anatomy 0.000 description 11
238000009792 diffusion process Methods 0.000 description 10
239000000499 gel Substances 0.000 description 9
210000001519 tissue Anatomy 0.000 description 9
206010021143 Hypoxia Diseases 0.000 description 8
238000010586 diagram Methods 0.000 description 8
239000012530 fluid Substances 0.000 description 7
230000001146 hypoxic effect Effects 0.000 description 7
230000000699 topical effect Effects 0.000 description 7
102000008186 Collagen Human genes 0.000 description 6
108010035532 Collagen Proteins 0.000 description 6
210000004369 blood Anatomy 0.000 description 6
239000008280 blood Substances 0.000 description 6
229920001436 collagen Polymers 0.000 description 6
210000002950 fibroblast Anatomy 0.000 description 6
210000002381 plasma Anatomy 0.000 description 6
230000033115 angiogenesis Effects 0.000 description 5
230000008901 benefit Effects 0.000 description 5
230000015572 biosynthetic process Effects 0.000 description 5
230000035699 permeability Effects 0.000 description 5
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
208000025865 Ulcer Diseases 0.000 description 4
230000000222 hyperoxic effect Effects 0.000 description 4
238000012986 modification Methods 0.000 description 4
230000004048 modification Effects 0.000 description 4
230000008569 process Effects 0.000 description 4
238000003786 synthesis reaction Methods 0.000 description 4
231100000397 ulcer Toxicity 0.000 description 4
241001465754 Metazoa Species 0.000 description 3
UBAZGMLMVVQSCD-UHFFFAOYSA-N carbon dioxide;molecular oxygen Chemical compound O=O.O=C=O UBAZGMLMVVQSCD-UHFFFAOYSA-N 0.000 description 3
230000001684 chronic effect Effects 0.000 description 3
239000000470 constituent Substances 0.000 description 3
238000013461 design Methods 0.000 description 3
230000000694 effects Effects 0.000 description 3
210000002683 foot Anatomy 0.000 description 3
208000015181 infectious disease Diseases 0.000 description 3
239000011148 porous material Substances 0.000 description 3
229920006395 saturated elastomer Polymers 0.000 description 3
230000002195 synergetic effect Effects 0.000 description 3
230000009885 systemic effect Effects 0.000 description 3
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 2
208000005230 Leg Ulcer Diseases 0.000 description 2
240000007711 Peperomia pellucida Species 0.000 description 2
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
238000010521 absorption reaction Methods 0.000 description 2
230000001154 acute effect Effects 0.000 description 2
239000000654 additive Substances 0.000 description 2
239000003242 anti bacterial agent Substances 0.000 description 2
230000000844 anti-bacterial effect Effects 0.000 description 2
230000000843 anti-fungal effect Effects 0.000 description 2
229940088710 antibiotic agent Drugs 0.000 description 2
229940121375 antifungal agent Drugs 0.000 description 2
239000012298 atmosphere Substances 0.000 description 2
230000036770 blood supply Effects 0.000 description 2
210000003169 central nervous system Anatomy 0.000 description 2
230000008859 change Effects 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
230000008602 contraction Effects 0.000 description 2
230000006378 damage Effects 0.000 description 2
230000000593 degrading effect Effects 0.000 description 2
238000012217 deletion Methods 0.000 description 2
230000037430 deletion Effects 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
210000004207 dermis Anatomy 0.000 description 2
PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
210000001339 epidermal cell Anatomy 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
210000003414 extremity Anatomy 0.000 description 2
229960002591 hydroxyproline Drugs 0.000 description 2
208000014674 injury Diseases 0.000 description 2
230000000302 ischemic effect Effects 0.000 description 2
238000009790 rate-determining step (RDS) Methods 0.000 description 2
239000012047 saturated solution Substances 0.000 description 2
230000018040 scab formation Effects 0.000 description 2
239000000126 substance Substances 0.000 description 2
238000006467 substitution reaction Methods 0.000 description 2
238000001356 surgical procedure Methods 0.000 description 2
231100000419 toxicity Toxicity 0.000 description 2
230000001988 toxicity Effects 0.000 description 2
FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 2
241000700198 Cavia Species 0.000 description 1
241001112695 Clostridiales Species 0.000 description 1
241000193403 Clostridium Species 0.000 description 1
241000193468 Clostridium perfringens Species 0.000 description 1
241000193466 Clostridium septicum Species 0.000 description 1
206010011409 Cross infection Diseases 0.000 description 1
206010063560 Excessive granulation tissue Diseases 0.000 description 1
201000000628 Gas Gangrene Diseases 0.000 description 1
102000001554 Hemoglobins Human genes 0.000 description 1
108010054147 Hemoglobins Proteins 0.000 description 1
208000035901 Ischaemic ulcer Diseases 0.000 description 1
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
SPAGIJMPHSUYSE-UHFFFAOYSA-N Magnesium peroxide Chemical compound [Mg+2].[O-][O-] SPAGIJMPHSUYSE-UHFFFAOYSA-N 0.000 description 1
206010029803 Nosocomial infection Diseases 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
208000018262 Peripheral vascular disease Diseases 0.000 description 1
229920001328 Polyvinylidene chloride Polymers 0.000 description 1
208000004210 Pressure Ulcer Diseases 0.000 description 1
206010039509 Scab Diseases 0.000 description 1
206010040943 Skin Ulcer Diseases 0.000 description 1
206010072170 Skin wound Diseases 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
239000002390 adhesive tape Substances 0.000 description 1
230000032683 aging Effects 0.000 description 1
210000003423 ankle Anatomy 0.000 description 1
238000013459 approach Methods 0.000 description 1
229960005070 ascorbic acid Drugs 0.000 description 1
235000010323 ascorbic acid Nutrition 0.000 description 1
239000011668 ascorbic acid Substances 0.000 description 1
230000001851 biosynthetic effect Effects 0.000 description 1
210000004204 blood vessel Anatomy 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
210000004027 cell Anatomy 0.000 description 1
230000012292 cell migration Effects 0.000 description 1
230000019522 cellular metabolic process Effects 0.000 description 1
230000007797 corrosion Effects 0.000 description 1
238000005260 corrosion Methods 0.000 description 1
238000001804 debridement Methods 0.000 description 1
230000007423 decrease Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
229940124448 dermatologic drug Drugs 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
VTIIJXUACCWYHX-UHFFFAOYSA-L disodium;carboxylatooxy carbonate Chemical compound [Na+].[Na+].[O-]C(=O)OOC([O-])=O VTIIJXUACCWYHX-UHFFFAOYSA-L 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
238000001647 drug administration Methods 0.000 description 1
230000008508 epithelial proliferation Effects 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
238000009920 food preservation Methods 0.000 description 1
238000009472 formulation Methods 0.000 description 1
230000035784 germination Effects 0.000 description 1
238000005469 granulation Methods 0.000 description 1
230000003179 granulation Effects 0.000 description 1
210000001126 granulation tissue Anatomy 0.000 description 1
230000005484 gravity Effects 0.000 description 1
239000000017 hydrogel Substances 0.000 description 1
229960002163 hydrogen peroxide Drugs 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
230000007954 hypoxia Effects 0.000 description 1
230000006872 improvement Effects 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
208000028867 ischemia Diseases 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
229960004995 magnesium peroxide Drugs 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
239000011104 metalized film Substances 0.000 description 1
230000004089 microcirculation Effects 0.000 description 1
230000005012 migration Effects 0.000 description 1
238000013508 migration Methods 0.000 description 1
230000001617 migratory effect Effects 0.000 description 1
239000000203 mixture Substances 0.000 description 1
230000035764 nutrition Effects 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
229940023490 ophthalmic product Drugs 0.000 description 1
230000036284 oxygen consumption Effects 0.000 description 1
244000052769 pathogen Species 0.000 description 1
230000001766 physiological effect Effects 0.000 description 1
239000002985 plastic film Substances 0.000 description 1
229920006255 plastic film Polymers 0.000 description 1
239000005033 polyvinylidene chloride Substances 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
230000005855 radiation Effects 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000037309 reepithelialization Effects 0.000 description 1
230000008929 regeneration Effects 0.000 description 1
238000011069 regeneration method Methods 0.000 description 1
238000011160 research Methods 0.000 description 1
238000012552 review Methods 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
229920006268 silicone film Polymers 0.000 description 1
231100000245 skin permeability Toxicity 0.000 description 1
231100000019 skin ulcer Toxicity 0.000 description 1
229910000029 sodium carbonate Inorganic materials 0.000 description 1
229940001593 sodium carbonate Drugs 0.000 description 1
229940045872 sodium percarbonate Drugs 0.000 description 1
230000003068 static effect Effects 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
230000000287 tissue oxygenation Effects 0.000 description 1
239000003860 topical agent Substances 0.000 description 1
230000002792 vascular Effects 0.000 description 1
230000037314 wound repair Effects 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M35/00—Devices for applying media, e.g. remedies, on the human body
- A61M35/30—Gas therapy for therapeutic treatment of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H33/00—Bathing devices for special therapeutic or hygienic purposes
- A61H33/14—Devices for gas baths with ozone, hydrogen, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H35/00—Baths for specific parts of the body

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Anesthesiology (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Materials For Medical Uses (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Separation Using Semi-Permeable Membranes (AREA)

CA2529516A 2003-06-18 2004-06-18 Procede et appareil permettant de fournir un gaz a une zone Expired - Fee Related CA2529516C (fr)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
US47974503P	2003-06-18	2003-06-18
US60/479,745		2003-06-18
US10/781,965		2004-02-18
US10/781,965 US7014630B2 (en)	2003-06-18	2004-02-18	Tissue dressing having gas reservoir
US55163804P	2004-03-08	2004-03-08
US60/551,638		2004-03-08
PCT/US2004/019599 WO2004112649A2 (fr)	2003-06-18	2004-06-18	Procede et appareil permettant de fournir un gaz a une zone

Publications (2)

Publication Number	Publication Date
CA2529516A1 CA2529516A1 (fr)	2004-12-29
CA2529516C true CA2529516C (fr)	2012-06-12

Family

ID=33545339

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2529516A Expired - Fee Related CA2529516C (fr)	2003-06-18	2004-06-18	Procede et appareil permettant de fournir un gaz a une zone

Country Status (8)

Country	Link
EP (1)	EP1644071A4 (fr)
JP (1)	JP4750023B2 (fr)
CN (1)	CN1838976B (fr)
AU (1)	AU2004249259B2 (fr)
BR (1)	BRPI0411651A (fr)
CA (1)	CA2529516C (fr)
MX (1)	MXPA05013786A (fr)
WO (1)	WO2004112649A2 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6702949B2 (en)	1997-10-24	2004-03-09	Microdiffusion, Inc.	Diffuser/emulsifier for aquaculture applications
JP2008529739A (ja) *	2005-02-17	2008-08-07	オキシバンドテクノロジーズインコーポレイテッド	ガスをエリアに供給する方法および装置
EP2083876A4 (fr) *	2006-10-25	2012-09-19	Revalesio Corp	Méthodes de soins et de traitement de plaies
US8445546B2 (en)	2006-10-25	2013-05-21	Revalesio Corporation	Electrokinetically-altered fluids comprising charge-stabilized gas-containing nanostructures
JP5306214B2 (ja)	2006-10-25	2013-10-02	リバルシオコーポレイション	混合装置
CA2667791A1 (fr) *	2006-10-25	2008-05-02	Revalesio Corporation	Procedes de traitement therapeutique des yeux et d'autres tissus humains a l'aide d'une solution enrichie en oxygene
US9523090B2 (en)	2007-10-25	2016-12-20	Revalesio Corporation	Compositions and methods for treating inflammation
US10125359B2 (en)	2007-10-25	2018-11-13	Revalesio Corporation	Compositions and methods for treating inflammation
US9745567B2 (en)	2008-04-28	2017-08-29	Revalesio Corporation	Compositions and methods for treating multiple sclerosis
CA2723215A1 (fr)	2008-05-01	2009-11-05	Revalesio Corporation	Compositions et methodes de traitement de troubles digestifs
SE0801490A0 (sv) *	2008-06-24	2009-12-25	Moelnlycke Health Care Ab	Sårförband
US8815292B2 (en)	2009-04-27	2014-08-26	Revalesio Corporation	Compositions and methods for treating insulin resistance and diabetes mellitus
CN104983740A (zh)	2010-05-07	2015-10-21	利发利希奥公司	用于增强生理性能和恢复时间的组合物和方法
JP2013533320A (ja)	2010-08-12	2013-08-22	レバレジオコーポレイション	タウオパチーを治療するための組成物および方法
CN105749410A (zh) *	2014-07-13	2016-07-13	王丽	疤痕修复用新型指套
CN105664350A (zh) *	2014-07-13	2016-06-15	王丽	一种用于美容的指套
CN105664349A (zh) *	2014-07-13	2016-06-15	王丽	美容用新型指套
CN105749411A (zh) *	2014-07-13	2016-07-13	王丽	一种疤痕修复用新型医疗指套
CN105664351A (zh) *	2014-07-13	2016-06-15	王丽	用于疤痕修复节约成本的医疗指套
CN105536135A (zh) *	2014-07-13	2016-05-04	王丽	新型疤痕修复指套
CN105749409A (zh) *	2014-07-13	2016-07-13	王丽	用于疤痕修复的指套
RU2017144898A (ru) *	2015-06-30	2019-06-20	Кимберли-Кларк Ворлдвайд, Инк.	Пластырь из вспененного гидрогеля для доставки кислорода и способ получения
CN106861051A (zh) *	2017-03-30	2017-06-20	长春长理光学精密机械有限公司	一种能封闭光辐射和气体的治疗装置
CN107874913A (zh) *	2017-12-19	2018-04-06	大连海事大学	一种基于液体材料供氧的伤口敷料及其生产方法
CN107961114A (zh) *	2017-12-19	2018-04-27	大连海事大学	一种基于固体颗粒供氧的伤口敷料及其生产方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4747841A (en) *	1985-03-19	1988-05-31	Yasuro Kuratomi	Methods and instruments of moxibustion
JPS645548A (en) *	1987-06-29	1989-01-10	Paramount Bed Kk	Bedsore treatment aid device
CA2137275A1 (fr) *	1992-06-03	1993-12-09	Richard L. Eckert	Bandage servant a l'application continue de produits biologiques
US5788682A (en) *	1995-04-28	1998-08-04	Maget; Henri J.R.	Apparatus and method for controlling oxygen concentration in the vicinity of a wound
US5792090A (en) *	1995-06-15	1998-08-11	Ladin; Daniel	Oxygen generating wound dressing
EP0999041A3 (fr) *	1998-11-03	2001-01-31	Mitsubishi Polyester Film GmbH	Feuille multicouche comprenant une feuille de polyester orientée biaxialement présentant des bonnes propriétés de barrière à l'oxygène, procédé de fabrication et utilisation
WO2000074616A1 (fr) *	1999-06-02	2000-12-14	Tano Robert S	Pansement de premiers soins a usages multiples
WO2001005445A2 (fr) *	1999-07-19	2001-01-25	Coloplast A/S	Dispositif generant du dioxyde de carbone
US6471685B1 (en) *	2000-05-18	2002-10-29	David James Johnson	Medical dressing assembly and associated method of using the same
US6767342B1 (en) *	2001-04-23	2004-07-27	Evelyna D. Cantwell	Oxygen bandage system

2004
- 2004-06-18 BR BRPI0411651-8A patent/BRPI0411651A/pt not_active IP Right Cessation
- 2004-06-18 MX MXPA05013786A patent/MXPA05013786A/es active IP Right Grant
- 2004-06-18 CA CA2529516A patent/CA2529516C/fr not_active Expired - Fee Related
- 2004-06-18 AU AU2004249259A patent/AU2004249259B2/en not_active Ceased
- 2004-06-18 JP JP2006517434A patent/JP4750023B2/ja not_active Expired - Fee Related
- 2004-06-18 EP EP04755643.6A patent/EP1644071A4/fr not_active Withdrawn
- 2004-06-18 WO PCT/US2004/019599 patent/WO2004112649A2/fr not_active Ceased
- 2004-06-18 CN CN2004800237859A patent/CN1838976B/zh not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU2004249259A2 (en)	2004-12-29
CN1838976B (zh)	2011-11-09
MXPA05013786A (es)	2006-02-28
AU2004249259A1 (en)	2004-12-29
WO2004112649A3 (fr)	2005-05-12
EP1644071A4 (fr)	2013-11-27
JP2007524447A (ja)	2007-08-30
CA2529516A1 (fr)	2004-12-29
WO2004112649A2 (fr)	2004-12-29
EP1644071A2 (fr)	2006-04-12
JP4750023B2 (ja)	2011-08-17
CN1838976A (zh)	2006-09-27
BRPI0411651A (pt)	2006-08-08
AU2004249259B2 (en)	2011-04-07

Legal Events

Date	Code	Title	Description
2007-05-30	EEER	Examination request
2014-07-30	MKLA	Lapsed	Effective date: 20140618

Publication	Publication Date	Title
US7014630B2 (en)	2006-03-21	Tissue dressing having gas reservoir
CA2529516C (fr)	2012-06-12	Procede et appareil permettant de fournir un gaz a une zone
US7762045B2 (en)	2010-07-27	Method and apparatus for supplying gas to an area
US5792090A (en)	1998-08-11	Oxygen generating wound dressing
AU716088B2 (en)	2000-02-17	Oxygen producing bandage
US8166731B2 (en)	2012-05-01	Method and apparatus for supplying gas to an area
US20120046603A1 (en)	2012-02-23	Hyperbaric dressing and method
US10413449B2 (en)	2019-09-17	Oxygen-generating wound dressing
MX2007010053A (es)	2008-08-31	Metodo y aparato para suministrar gas a un a
US9044462B2 (en)	2015-06-02	Method for oxygen treatment of intact skin
US20250268932A1 (en)	2025-08-28	Oxygen-containing preparation for treating acne and wounds, a preparation method and an application device thereof
WO2001005445A2 (fr)	2001-01-25	Dispositif generant du dioxyde de carbone
CN101626805A (zh)	2010-01-13	利用超声波的氧疗